Show
Sort by
-
'In-house' data on the outside : a mobile health approach
-
Switchability of gabapentin formulations : a randomized trial to assess bioequivalence between Neurontin and Gabasandoz on the individual subject level
-
Mobile health technology captures 'in-house' data on the outside : an assessment with pharmacological intervention
-
Pharmacokinetic and pharmacodynamic relationships of copanlisib in patients with non-Hodgkin lymphoma and advanced solid tumors
-
- Journal Article
- A1
- open access
Pharmacology and therapeutics education in the European Union needs harmonization and modernization : a cross-sectional survey among 185 medical schools in 27 countries
-
- Journal Article
- A1
- open access
Essential competencies in prescribing : a first European cross-sectional study among 895 final-year medical students
-
Plasma exposure to metabolites of monomethyl auristatin E (MMAE) in patients with relapsed/refractory Hodgkin lymphoma (HL) treated with brentuximab vedotin (BV)
-
The single dose pharmacokinetic (PK) and pharmacodynamic (PD) profiles of suvorexant (MK-4305); a dual orexin receptor antagonist, in healthy male subjects
-
THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF TELCAGEPANT, A NOVEL CALCITONIN GENE RELATED PEPTIDE (CGRP) RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS AND MIGRAINEURS
-
An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment